Hyderabad: Laurus Labs has signed an investment agreement with Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an ...

Laurus Labs has received a tentative nod from the Food and Drug Administration for Dolutegravir 5 mg and 10 mg for pediatric ARV treatment. This pediatric drug administration through oral dispersible ...

Bajaj Broking has a buy call on Laurus Labs with a target price of Rs 710. The current market price of Laurus Labs is Rs 565.4. The time period given by the analyst is a year when Laurus Labs price ...

Laurus Labs has seen a notable increase in its consensus analyst price target, which has risen from ₹724.14 to ₹815.86. This revision follows renewed analyst optimism, attributed largely to the ...

The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the ...

Laurus Labs Share Price: Laurus Labs shares today crashed 17 per cent despite the company reported better-than-expected results in the third quarter (Q3 FY2025). Laurus Labs share opened at Rs nearly ...

Get the latest news today on Laurus Labs Ltd. Follow Business Standard for the complete news coverage and key information about the Laurus Labs Ltd.

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! It is not uncommon to see companies perform well in the years after insiders ...

Laurus Labs is a company based in Hyderabad, Telangana, India, operating in the healthtech sector. Founded in 2005, it now employs 2757 individuals. The company was established by Satyanarayana Chava.

Earnings call Laurus Labs reported Q2FY26 revenue of ₹1,653 crore, up 35% YoY, driven by strong ARV and CDMO performance. EBITDA margin expanded to 26%, aided by operating leverage and product mix.

Laurus Labs is a company based in Hyderabad, Telangana, India, operating in the healthtech sector. Founded in 2005, it now employs 2757 individuals. The company was established by Satyanarayana Chava.

Auto industry experts predict the move will drive up prices and stymie production. Shares of automakers fell in after-hours trading. category China tells state firms to halt deals with Li Ka-shing and ...